Fuse Medical, Inc.
Fuse Medical, Inc. (FZMD) Stock Competitors & Peer Comparison
See (FZMD) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| FZMD | $0.02 | -26.67% | 2M | 1.35 | $0.02 | N/A |
| SEMHF | $39.53 | -1.06% | 45.4B | 18.27 | $2.22 | +3.01% |
| RYLPF | $27.25 | +1.20% | 25.9B | 23.29 | $1.17 | +3.49% |
| SMMNY | $19.83 | -0.06% | 22B | 17.73 | $1.11 | +3.01% |
| SONVY | $45.43 | -1.22% | 13.5B | 20.19 | $2.24 | +2.38% |
| SONVF | $224.67 | -3.30% | 13.4B | 20.10 | $11.18 | +2.41% |
| SNNUF | $14.95 | +0.00% | 12.8B | 20.76 | $0.72 | +2.63% |
| WILYY | $18.82 | +2.84% | 7.8B | 21.10 | $0.88 | N/A |
| WILLF | $34.10 | -4.16% | 7.2B | 19.38 | $1.76 | N/A |
| GNGBF | $23.23 | +0.00% | 5.9B | 25.25 | $0.92 | +2.22% |
Stock Comparison
FZMD vs SEMHF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, SEMHF has a market cap of 45.4B. Regarding current trading prices, FZMD is priced at $0.02, while SEMHF trades at $39.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas SEMHF's P/E ratio is 18.27. In terms of profitability, FZMD's ROE is +0.13%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, FZMD is less volatile compared to SEMHF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check SEMHF's competition here
FZMD vs RYLPF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, RYLPF has a market cap of 25.9B. Regarding current trading prices, FZMD is priced at $0.02, while RYLPF trades at $27.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas RYLPF's P/E ratio is 23.29. In terms of profitability, FZMD's ROE is +0.13%, compared to RYLPF's ROE of +0.09%. Regarding short-term risk, FZMD and RYLPF have similar daily volatility (0.00).Check RYLPF's competition here
FZMD vs SMMNY Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, SMMNY has a market cap of 22B. Regarding current trading prices, FZMD is priced at $0.02, while SMMNY trades at $19.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas SMMNY's P/E ratio is 17.73. In terms of profitability, FZMD's ROE is +0.13%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, FZMD is less volatile compared to SMMNY. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check SMMNY's competition here
FZMD vs SONVY Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, SONVY has a market cap of 13.5B. Regarding current trading prices, FZMD is priced at $0.02, while SONVY trades at $45.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas SONVY's P/E ratio is 20.19. In terms of profitability, FZMD's ROE is +0.13%, compared to SONVY's ROE of +0.20%. Regarding short-term risk, FZMD is less volatile compared to SONVY. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check SONVY's competition here
FZMD vs SONVF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, SONVF has a market cap of 13.4B. Regarding current trading prices, FZMD is priced at $0.02, while SONVF trades at $224.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas SONVF's P/E ratio is 20.10. In terms of profitability, FZMD's ROE is +0.13%, compared to SONVF's ROE of +0.20%. Regarding short-term risk, FZMD is less volatile compared to SONVF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check SONVF's competition here
FZMD vs SNNUF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, SNNUF has a market cap of 12.8B. Regarding current trading prices, FZMD is priced at $0.02, while SNNUF trades at $14.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas SNNUF's P/E ratio is 20.76. In terms of profitability, FZMD's ROE is +0.13%, compared to SNNUF's ROE of +0.12%. Regarding short-term risk, FZMD and SNNUF have similar daily volatility (0.00).Check SNNUF's competition here
FZMD vs WILYY Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, WILYY has a market cap of 7.8B. Regarding current trading prices, FZMD is priced at $0.02, while WILYY trades at $18.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas WILYY's P/E ratio is 21.10. In terms of profitability, FZMD's ROE is +0.13%, compared to WILYY's ROE of +0.16%. Regarding short-term risk, FZMD and WILYY have similar daily volatility (0.00).Check WILYY's competition here
FZMD vs WILLF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, WILLF has a market cap of 7.2B. Regarding current trading prices, FZMD is priced at $0.02, while WILLF trades at $34.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas WILLF's P/E ratio is 19.38. In terms of profitability, FZMD's ROE is +0.13%, compared to WILLF's ROE of +0.16%. Regarding short-term risk, FZMD is less volatile compared to WILLF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check WILLF's competition here
FZMD vs GNGBF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, GNGBF has a market cap of 5.9B. Regarding current trading prices, FZMD is priced at $0.02, while GNGBF trades at $23.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas GNGBF's P/E ratio is 25.25. In terms of profitability, FZMD's ROE is +0.13%, compared to GNGBF's ROE of +0.08%. Regarding short-term risk, FZMD and GNGBF have similar daily volatility (0.00).Check GNGBF's competition here
FZMD vs GNGBY Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, GNGBY has a market cap of 5.7B. Regarding current trading prices, FZMD is priced at $0.02, while GNGBY trades at $20.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas GNGBY's P/E ratio is 22.18. In terms of profitability, FZMD's ROE is +0.13%, compared to GNGBY's ROE of +0.08%. Regarding short-term risk, FZMD is less volatile compared to GNGBY. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check GNGBY's competition here
FZMD vs CHEOF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, CHEOF has a market cap of 4.8B. Regarding current trading prices, FZMD is priced at $0.02, while CHEOF trades at $73.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas CHEOF's P/E ratio is 19.30. In terms of profitability, FZMD's ROE is +0.13%, compared to CHEOF's ROE of +0.18%. Regarding short-term risk, FZMD and CHEOF have similar daily volatility (0.00).Check CHEOF's competition here
FZMD vs CHEOY Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, CHEOY has a market cap of 4.8B. Regarding current trading prices, FZMD is priced at $0.02, while CHEOY trades at $36.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas CHEOY's P/E ratio is 19.19. In terms of profitability, FZMD's ROE is +0.13%, compared to CHEOY's ROE of +0.18%. Regarding short-term risk, FZMD is less volatile compared to CHEOY. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check CHEOY's competition here
FZMD vs AMBFF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, AMBFF has a market cap of 3.4B. Regarding current trading prices, FZMD is priced at $0.02, while AMBFF trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas AMBFF's P/E ratio is 46.43. In terms of profitability, FZMD's ROE is +0.13%, compared to AMBFF's ROE of +0.08%. Regarding short-term risk, FZMD and AMBFF have similar daily volatility (0.00).Check AMBFF's competition here
FZMD vs NHNKY Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, NHNKY has a market cap of 3B. Regarding current trading prices, FZMD is priced at $0.02, while NHNKY trades at $9.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas NHNKY's P/E ratio is 13.24. In terms of profitability, FZMD's ROE is +0.13%, compared to NHNKY's ROE of +0.07%. Regarding short-term risk, FZMD is less volatile compared to NHNKY. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check NHNKY's competition here
FZMD vs AMBBY Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, AMBBY has a market cap of 2.6B. Regarding current trading prices, FZMD is priced at $0.02, while AMBBY trades at $9.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas AMBBY's P/E ratio is 34.91. In terms of profitability, FZMD's ROE is +0.13%, compared to AMBBY's ROE of +0.08%. Regarding short-term risk, FZMD and AMBBY have similar daily volatility (0.00).Check AMBBY's competition here
FZMD vs GNNDY Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, GNNDY has a market cap of 2.2B. Regarding current trading prices, FZMD is priced at $0.02, while GNNDY trades at $45.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas GNNDY's P/E ratio is 53.86. In terms of profitability, FZMD's ROE is +0.13%, compared to GNNDY's ROE of -0.04%. Regarding short-term risk, FZMD is less volatile compared to GNNDY. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check GNNDY's competition here
FZMD vs OSSFF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, OSSFF has a market cap of 2.2B. Regarding current trading prices, FZMD is priced at $0.02, while OSSFF trades at $5.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas OSSFF's P/E ratio is 25.55. In terms of profitability, FZMD's ROE is +0.13%, compared to OSSFF's ROE of +0.10%. Regarding short-term risk, FZMD and OSSFF have similar daily volatility (0.00).Check OSSFF's competition here
FZMD vs MCRPF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, MCRPF has a market cap of 2.2B. Regarding current trading prices, FZMD is priced at $0.02, while MCRPF trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas MCRPF's P/E ratio is -12.67. In terms of profitability, FZMD's ROE is +0.13%, compared to MCRPF's ROE of +0.06%. Regarding short-term risk, FZMD and MCRPF have similar daily volatility (0.00).Check MCRPF's competition here
FZMD vs DRWKF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, DRWKF has a market cap of 2.1B. Regarding current trading prices, FZMD is priced at $0.02, while DRWKF trades at $111.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas DRWKF's P/E ratio is 11.67. In terms of profitability, FZMD's ROE is +0.13%, compared to DRWKF's ROE of +0.10%. Regarding short-term risk, FZMD is less volatile compared to DRWKF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check DRWKF's competition here
FZMD vs GGNDF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, GGNDF has a market cap of 2.1B. Regarding current trading prices, FZMD is priced at $0.02, while GGNDF trades at $14.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas GGNDF's P/E ratio is 50.39. In terms of profitability, FZMD's ROE is +0.13%, compared to GGNDF's ROE of -0.04%. Regarding short-term risk, FZMD is less volatile compared to GGNDF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check GGNDF's competition here
FZMD vs DWRKF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, FZMD is priced at $0.02, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, FZMD's ROE is +0.13%, compared to DWRKF's ROE of N/A. Regarding short-term risk, FZMD and DWRKF have similar daily volatility (0.00).Check DWRKF's competition here
FZMD vs NHNKF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, NHNKF has a market cap of 1.7B. Regarding current trading prices, FZMD is priced at $0.02, while NHNKF trades at $10.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas NHNKF's P/E ratio is 30.28. In terms of profitability, FZMD's ROE is +0.13%, compared to NHNKF's ROE of +0.07%. Regarding short-term risk, FZMD and NHNKF have similar daily volatility (0.00).Check NHNKF's competition here
FZMD vs OSSUY Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, OSSUY has a market cap of 1.7B. Regarding current trading prices, FZMD is priced at $0.02, while OSSUY trades at $4.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas OSSUY's P/E ratio is 20.05. In terms of profitability, FZMD's ROE is +0.13%, compared to OSSUY's ROE of +0.10%. Regarding short-term risk, FZMD and OSSUY have similar daily volatility (0.00).Check OSSUY's competition here
FZMD vs STSEY Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, STSEY has a market cap of 1.7B. Regarding current trading prices, FZMD is priced at $0.02, while STSEY trades at $5.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas STSEY's P/E ratio is 18.37. In terms of profitability, FZMD's ROE is +0.13%, compared to STSEY's ROE of -0.00%. Regarding short-term risk, FZMD and STSEY have similar daily volatility (0.00).Check STSEY's competition here
FZMD vs MEDGF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, FZMD is priced at $0.02, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, FZMD's ROE is +0.13%, compared to MEDGF's ROE of +0.22%. Regarding short-term risk, FZMD and MEDGF have similar daily volatility (0.00).Check MEDGF's competition here
FZMD vs FDMDF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, FDMDF has a market cap of 1.7B. Regarding current trading prices, FZMD is priced at $0.02, while FDMDF trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas FDMDF's P/E ratio is -9.66. In terms of profitability, FZMD's ROE is +0.13%, compared to FDMDF's ROE of -9.21%. Regarding short-term risk, FZMD is less volatile compared to FDMDF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check FDMDF's competition here
FZMD vs VTRLY Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, VTRLY has a market cap of 1.5B. Regarding current trading prices, FZMD is priced at $0.02, while VTRLY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas VTRLY's P/E ratio is -2.75. In terms of profitability, FZMD's ROE is +0.13%, compared to VTRLY's ROE of -0.47%. Regarding short-term risk, FZMD and VTRLY have similar daily volatility (0.00).Check VTRLY's competition here
FZMD vs MDRSF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, MDRSF has a market cap of 1.4B. Regarding current trading prices, FZMD is priced at $0.02, while MDRSF trades at $115.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas MDRSF's P/E ratio is 133.72. In terms of profitability, FZMD's ROE is +0.13%, compared to MDRSF's ROE of +0.03%. Regarding short-term risk, FZMD and MDRSF have similar daily volatility (0.00).Check MDRSF's competition here
FZMD vs DGWPF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, DGWPF has a market cap of 1.4B. Regarding current trading prices, FZMD is priced at $0.02, while DGWPF trades at $72.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas DGWPF's P/E ratio is 7.53. In terms of profitability, FZMD's ROE is +0.13%, compared to DGWPF's ROE of +0.10%. Regarding short-term risk, FZMD and DGWPF have similar daily volatility (0.00).Check DGWPF's competition here
FZMD vs LFTSF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, LFTSF has a market cap of 858.1M. Regarding current trading prices, FZMD is priced at $0.02, while LFTSF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas LFTSF's P/E ratio is 19.50. In terms of profitability, FZMD's ROE is +0.13%, compared to LFTSF's ROE of +0.02%. Regarding short-term risk, FZMD is less volatile compared to LFTSF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check LFTSF's competition here
FZMD vs ELEAF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, ELEAF has a market cap of 759.8M. Regarding current trading prices, FZMD is priced at $0.02, while ELEAF trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas ELEAF's P/E ratio is 12.99. In terms of profitability, FZMD's ROE is +0.13%, compared to ELEAF's ROE of +0.16%. Regarding short-term risk, FZMD is less volatile compared to ELEAF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check ELEAF's competition here
FZMD vs XVIPF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, XVIPF has a market cap of 603.2M. Regarding current trading prices, FZMD is priced at $0.02, while XVIPF trades at $19.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas XVIPF's P/E ratio is 76.60. In terms of profitability, FZMD's ROE is +0.13%, compared to XVIPF's ROE of +0.03%. Regarding short-term risk, FZMD is less volatile compared to XVIPF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check XVIPF's competition here
FZMD vs BRSYF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, BRSYF has a market cap of 542.4M. Regarding current trading prices, FZMD is priced at $0.02, while BRSYF trades at $13.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas BRSYF's P/E ratio is 75.28. In terms of profitability, FZMD's ROE is +0.13%, compared to BRSYF's ROE of +0.11%. Regarding short-term risk, FZMD is less volatile compared to BRSYF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check BRSYF's competition here
FZMD vs CALZF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, CALZF has a market cap of 514.1M. Regarding current trading prices, FZMD is priced at $0.02, while CALZF trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas CALZF's P/E ratio is 74.41. In terms of profitability, FZMD's ROE is +0.13%, compared to CALZF's ROE of +0.12%. Regarding short-term risk, FZMD is less volatile compared to CALZF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check CALZF's competition here
FZMD vs IOBCF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, IOBCF has a market cap of 501.5M. Regarding current trading prices, FZMD is priced at $0.02, while IOBCF trades at $17.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas IOBCF's P/E ratio is 34.90. In terms of profitability, FZMD's ROE is +0.13%, compared to IOBCF's ROE of +0.10%. Regarding short-term risk, FZMD and IOBCF have similar daily volatility (0.00).Check IOBCF's competition here
FZMD vs AVMR Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, FZMD is priced at $0.02, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas AVMR's P/E ratio is -18.34. In terms of profitability, FZMD's ROE is +0.13%, compared to AVMR's ROE of -0.30%. Regarding short-term risk, FZMD and AVMR have similar daily volatility (0.00).Check AVMR's competition here
FZMD vs DMTRF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, DMTRF has a market cap of 476M. Regarding current trading prices, FZMD is priced at $0.02, while DMTRF trades at $3.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas DMTRF's P/E ratio is -198.00. In terms of profitability, FZMD's ROE is +0.13%, compared to DMTRF's ROE of +0.36%. Regarding short-term risk, FZMD is less volatile compared to DMTRF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check DMTRF's competition here
FZMD vs HYBT Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, FZMD is priced at $0.02, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas HYBT's P/E ratio is N/A. In terms of profitability, FZMD's ROE is +0.13%, compared to HYBT's ROE of +0.02%. Regarding short-term risk, FZMD and HYBT have similar daily volatility (0.00).Check HYBT's competition here
FZMD vs CLVSF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, CLVSF has a market cap of 321.8M. Regarding current trading prices, FZMD is priced at $0.02, while CLVSF trades at $13.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas CLVSF's P/E ratio is 22.11. In terms of profitability, FZMD's ROE is +0.13%, compared to CLVSF's ROE of +0.15%. Regarding short-term risk, FZMD is less volatile compared to CLVSF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check CLVSF's competition here
FZMD vs CYBQY Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, CYBQY has a market cap of 303.2M. Regarding current trading prices, FZMD is priced at $0.02, while CYBQY trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas CYBQY's P/E ratio is -170.00. In terms of profitability, FZMD's ROE is +0.13%, compared to CYBQY's ROE of -0.00%. Regarding short-term risk, FZMD and CYBQY have similar daily volatility (0.00).Check CYBQY's competition here
FZMD vs CSSPF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, CSSPF has a market cap of 273.5M. Regarding current trading prices, FZMD is priced at $0.02, while CSSPF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas CSSPF's P/E ratio is 32.50. In terms of profitability, FZMD's ROE is +0.13%, compared to CSSPF's ROE of +0.10%. Regarding short-term risk, FZMD is less volatile compared to CSSPF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check CSSPF's competition here
FZMD vs HTLZF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, FZMD is priced at $0.02, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, FZMD's ROE is +0.13%, compared to HTLZF's ROE of -0.01%. Regarding short-term risk, FZMD and HTLZF have similar daily volatility (0.00).Check HTLZF's competition here
FZMD vs IMPZY Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, IMPZY has a market cap of 229.3M. Regarding current trading prices, FZMD is priced at $0.02, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, FZMD's ROE is +0.13%, compared to IMPZY's ROE of +8.77%. Regarding short-term risk, FZMD and IMPZY have similar daily volatility (0.00).Check IMPZY's competition here
FZMD vs CYBQF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, CYBQF has a market cap of 206.8M. Regarding current trading prices, FZMD is priced at $0.02, while CYBQF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas CYBQF's P/E ratio is -155.00. In terms of profitability, FZMD's ROE is +0.13%, compared to CYBQF's ROE of -0.00%. Regarding short-term risk, FZMD and CYBQF have similar daily volatility (0.00).Check CYBQF's competition here
FZMD vs VMTHF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, VMTHF has a market cap of 186.1M. Regarding current trading prices, FZMD is priced at $0.02, while VMTHF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas VMTHF's P/E ratio is -3.01. In terms of profitability, FZMD's ROE is +0.13%, compared to VMTHF's ROE of -0.21%. Regarding short-term risk, FZMD and VMTHF have similar daily volatility (0.00).Check VMTHF's competition here
FZMD vs BCCOY Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, BCCOY has a market cap of 183.5M. Regarding current trading prices, FZMD is priced at $0.02, while BCCOY trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas BCCOY's P/E ratio is -1.14. In terms of profitability, FZMD's ROE is +0.13%, compared to BCCOY's ROE of -0.51%. Regarding short-term risk, FZMD and BCCOY have similar daily volatility (0.00).Check BCCOY's competition here
FZMD vs DTXMF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, DTXMF has a market cap of 180.6M. Regarding current trading prices, FZMD is priced at $0.02, while DTXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas DTXMF's P/E ratio is -9.52. In terms of profitability, FZMD's ROE is +0.13%, compared to DTXMF's ROE of -0.74%. Regarding short-term risk, FZMD is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check DTXMF's competition here
FZMD vs EKDHF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, EKDHF has a market cap of 167.9M. Regarding current trading prices, FZMD is priced at $0.02, while EKDHF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas EKDHF's P/E ratio is 39.00. In terms of profitability, FZMD's ROE is +0.13%, compared to EKDHF's ROE of +0.03%. Regarding short-term risk, FZMD and EKDHF have similar daily volatility (0.00).Check EKDHF's competition here
FZMD vs EAPIF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, EAPIF has a market cap of 162.8M. Regarding current trading prices, FZMD is priced at $0.02, while EAPIF trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas EAPIF's P/E ratio is -0.65. In terms of profitability, FZMD's ROE is +0.13%, compared to EAPIF's ROE of -0.24%. Regarding short-term risk, FZMD and EAPIF have similar daily volatility (0.00).Check EAPIF's competition here
FZMD vs BRNHF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, BRNHF has a market cap of 161.7M. Regarding current trading prices, FZMD is priced at $0.02, while BRNHF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas BRNHF's P/E ratio is -5.12. In terms of profitability, FZMD's ROE is +0.13%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, FZMD is less volatile compared to BRNHF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check BRNHF's competition here
FZMD vs CLLKF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, CLLKF has a market cap of 136.8M. Regarding current trading prices, FZMD is priced at $0.02, while CLLKF trades at $1.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas CLLKF's P/E ratio is -0.88. In terms of profitability, FZMD's ROE is +0.13%, compared to CLLKF's ROE of -0.52%. Regarding short-term risk, FZMD and CLLKF have similar daily volatility (0.00).Check CLLKF's competition here
FZMD vs AMEUF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, FZMD is priced at $0.02, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, FZMD's ROE is +0.13%, compared to AMEUF's ROE of -1.90%. Regarding short-term risk, FZMD is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check AMEUF's competition here
FZMD vs PXMBF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, PXMBF has a market cap of 119.9M. Regarding current trading prices, FZMD is priced at $0.02, while PXMBF trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas PXMBF's P/E ratio is 23.33. In terms of profitability, FZMD's ROE is +0.13%, compared to PXMBF's ROE of -0.04%. Regarding short-term risk, FZMD is less volatile compared to PXMBF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check PXMBF's competition here
FZMD vs SNZZF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, SNZZF has a market cap of 110.1M. Regarding current trading prices, FZMD is priced at $0.02, while SNZZF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas SNZZF's P/E ratio is -7.78. In terms of profitability, FZMD's ROE is +0.13%, compared to SNZZF's ROE of -0.38%. Regarding short-term risk, FZMD and SNZZF have similar daily volatility (0.00).Check SNZZF's competition here
FZMD vs AVHHL Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, AVHHL has a market cap of 102.7M. Regarding current trading prices, FZMD is priced at $0.02, while AVHHL trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas AVHHL's P/E ratio is -2.36. In terms of profitability, FZMD's ROE is +0.13%, compared to AVHHL's ROE of +4.77%. Regarding short-term risk, FZMD and AVHHL have similar daily volatility (0.00).Check AVHHL's competition here
FZMD vs SOMNF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, SOMNF has a market cap of 98.6M. Regarding current trading prices, FZMD is priced at $0.02, while SOMNF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas SOMNF's P/E ratio is -45.00. In terms of profitability, FZMD's ROE is +0.13%, compared to SOMNF's ROE of -0.05%. Regarding short-term risk, FZMD and SOMNF have similar daily volatility (0.00).Check SOMNF's competition here
FZMD vs JMDMF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, JMDMF has a market cap of 94.1M. Regarding current trading prices, FZMD is priced at $0.02, while JMDMF trades at $3.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas JMDMF's P/E ratio is -13.68. In terms of profitability, FZMD's ROE is +0.13%, compared to JMDMF's ROE of N/A. Regarding short-term risk, FZMD is less volatile compared to JMDMF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check JMDMF's competition here
FZMD vs RSHUF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, FZMD is priced at $0.02, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, FZMD's ROE is +0.13%, compared to RSHUF's ROE of -4.12%. Regarding short-term risk, FZMD is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check RSHUF's competition here
FZMD vs CKMTF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, FZMD is priced at $0.02, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, FZMD's ROE is +0.13%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, FZMD and CKMTF have similar daily volatility (0.00).Check CKMTF's competition here
FZMD vs BLOZF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, BLOZF has a market cap of 64.7M. Regarding current trading prices, FZMD is priced at $0.02, while BLOZF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas BLOZF's P/E ratio is -13.20. In terms of profitability, FZMD's ROE is +0.13%, compared to BLOZF's ROE of -3.03%. Regarding short-term risk, FZMD is less volatile compared to BLOZF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check BLOZF's competition here
FZMD vs TLTFF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, TLTFF has a market cap of 54.9M. Regarding current trading prices, FZMD is priced at $0.02, while TLTFF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas TLTFF's P/E ratio is -19.90. In terms of profitability, FZMD's ROE is +0.13%, compared to TLTFF's ROE of -3.15%. Regarding short-term risk, FZMD is less volatile compared to TLTFF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check TLTFF's competition here
FZMD vs NVYTF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, NVYTF has a market cap of 34.8M. Regarding current trading prices, FZMD is priced at $0.02, while NVYTF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas NVYTF's P/E ratio is -0.86. In terms of profitability, FZMD's ROE is +0.13%, compared to NVYTF's ROE of -1.25%. Regarding short-term risk, FZMD and NVYTF have similar daily volatility (0.00).Check NVYTF's competition here
FZMD vs RDGL Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, RDGL has a market cap of 29.9M. Regarding current trading prices, FZMD is priced at $0.02, while RDGL trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas RDGL's P/E ratio is -6.20. In terms of profitability, FZMD's ROE is +0.13%, compared to RDGL's ROE of -1.26%. Regarding short-term risk, FZMD is less volatile compared to RDGL. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check RDGL's competition here
FZMD vs POSC Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, POSC has a market cap of 26.1M. Regarding current trading prices, FZMD is priced at $0.02, while POSC trades at $1.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas POSC's P/E ratio is -5.38. In terms of profitability, FZMD's ROE is +0.13%, compared to POSC's ROE of -4.69%. Regarding short-term risk, FZMD is less volatile compared to POSC. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check POSC's competition here
FZMD vs MKEAF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, MKEAF has a market cap of 25.9M. Regarding current trading prices, FZMD is priced at $0.02, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, FZMD's ROE is +0.13%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, FZMD and MKEAF have similar daily volatility (0.00).Check MKEAF's competition here
FZMD vs TCLIF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, TCLIF has a market cap of 25.1M. Regarding current trading prices, FZMD is priced at $0.02, while TCLIF trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas TCLIF's P/E ratio is -4.84. In terms of profitability, FZMD's ROE is +0.13%, compared to TCLIF's ROE of +2.39%. Regarding short-term risk, FZMD is less volatile compared to TCLIF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check TCLIF's competition here
FZMD vs PYNKF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, PYNKF has a market cap of 24.9M. Regarding current trading prices, FZMD is priced at $0.02, while PYNKF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas PYNKF's P/E ratio is 3.96. In terms of profitability, FZMD's ROE is +0.13%, compared to PYNKF's ROE of -2.78%. Regarding short-term risk, FZMD is less volatile compared to PYNKF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check PYNKF's competition here
FZMD vs KBBTF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, FZMD is priced at $0.02, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, FZMD's ROE is +0.13%, compared to KBBTF's ROE of N/A. Regarding short-term risk, FZMD and KBBTF have similar daily volatility (0.00).Check KBBTF's competition here
FZMD vs EMITF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, EMITF has a market cap of 21.3M. Regarding current trading prices, FZMD is priced at $0.02, while EMITF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas EMITF's P/E ratio is -7.62. In terms of profitability, FZMD's ROE is +0.13%, compared to EMITF's ROE of -0.07%. Regarding short-term risk, FZMD and EMITF have similar daily volatility (0.00).Check EMITF's competition here
FZMD vs VPTDF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, VPTDF has a market cap of 18.5M. Regarding current trading prices, FZMD is priced at $0.02, while VPTDF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas VPTDF's P/E ratio is -4.94. In terms of profitability, FZMD's ROE is +0.13%, compared to VPTDF's ROE of +0.78%. Regarding short-term risk, FZMD is less volatile compared to VPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check VPTDF's competition here
FZMD vs DIZTF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, DIZTF has a market cap of 18M. Regarding current trading prices, FZMD is priced at $0.02, while DIZTF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas DIZTF's P/E ratio is -11.16. In terms of profitability, FZMD's ROE is +0.13%, compared to DIZTF's ROE of -0.52%. Regarding short-term risk, FZMD is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check DIZTF's competition here
FZMD vs GTHP Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, GTHP has a market cap of 16.9M. Regarding current trading prices, FZMD is priced at $0.02, while GTHP trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas GTHP's P/E ratio is -5.50. In terms of profitability, FZMD's ROE is +0.13%, compared to GTHP's ROE of +0.82%. Regarding short-term risk, FZMD and GTHP have similar daily volatility (0.00).Check GTHP's competition here
FZMD vs IPDQF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, IPDQF has a market cap of 16.3M. Regarding current trading prices, FZMD is priced at $0.02, while IPDQF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas IPDQF's P/E ratio is -0.80. In terms of profitability, FZMD's ROE is +0.13%, compared to IPDQF's ROE of -1.65%. Regarding short-term risk, FZMD and IPDQF have similar daily volatility (0.00).Check IPDQF's competition here
FZMD vs MDXHF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, MDXHF has a market cap of 14.4M. Regarding current trading prices, FZMD is priced at $0.02, while MDXHF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas MDXHF's P/E ratio is -4.40. In terms of profitability, FZMD's ROE is +0.13%, compared to MDXHF's ROE of +0.66%. Regarding short-term risk, FZMD and MDXHF have similar daily volatility (0.00).Check MDXHF's competition here
FZMD vs ASAPF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, ASAPF has a market cap of 14.1M. Regarding current trading prices, FZMD is priced at $0.02, while ASAPF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas ASAPF's P/E ratio is -18.12. In terms of profitability, FZMD's ROE is +0.13%, compared to ASAPF's ROE of -0.19%. Regarding short-term risk, FZMD is less volatile compared to ASAPF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check ASAPF's competition here
FZMD vs TMDIF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, FZMD is priced at $0.02, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, FZMD's ROE is +0.13%, compared to TMDIF's ROE of +8.70%. Regarding short-term risk, FZMD is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check TMDIF's competition here
FZMD vs ATBPF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, FZMD is priced at $0.02, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, FZMD's ROE is +0.13%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, FZMD is less volatile compared to ATBPF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check ATBPF's competition here
FZMD vs LXXGF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, FZMD is priced at $0.02, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, FZMD's ROE is +0.13%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, FZMD and LXXGF have similar daily volatility (0.00).Check LXXGF's competition here
FZMD vs ALRTF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, ALRTF has a market cap of 9.7M. Regarding current trading prices, FZMD is priced at $0.02, while ALRTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas ALRTF's P/E ratio is -0.38. In terms of profitability, FZMD's ROE is +0.13%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, FZMD and ALRTF have similar daily volatility (0.00).Check ALRTF's competition here
FZMD vs PLLWF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, PLLWF has a market cap of 8M. Regarding current trading prices, FZMD is priced at $0.02, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas PLLWF's P/E ratio is -0.66. In terms of profitability, FZMD's ROE is +0.13%, compared to PLLWF's ROE of -0.99%. Regarding short-term risk, FZMD is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check PLLWF's competition here
FZMD vs PMEDF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, PMEDF has a market cap of 7.3M. Regarding current trading prices, FZMD is priced at $0.02, while PMEDF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas PMEDF's P/E ratio is -3.53. In terms of profitability, FZMD's ROE is +0.13%, compared to PMEDF's ROE of +1.24%. Regarding short-term risk, FZMD is less volatile compared to PMEDF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check PMEDF's competition here
FZMD vs BIEL Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, BIEL has a market cap of 7.2M. Regarding current trading prices, FZMD is priced at $0.02, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas BIEL's P/E ratio is N/A. In terms of profitability, FZMD's ROE is +0.13%, compared to BIEL's ROE of +0.05%. Regarding short-term risk, FZMD is less volatile compared to BIEL. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check BIEL's competition here
FZMD vs USAQ Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, USAQ has a market cap of 6.3M. Regarding current trading prices, FZMD is priced at $0.02, while USAQ trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas USAQ's P/E ratio is 28.02. In terms of profitability, FZMD's ROE is +0.13%, compared to USAQ's ROE of -8.25%. Regarding short-term risk, FZMD and USAQ have similar daily volatility (0.00).Check USAQ's competition here
FZMD vs RMSL Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, RMSL has a market cap of 5.7M. Regarding current trading prices, FZMD is priced at $0.02, while RMSL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas RMSL's P/E ratio is 0.34. In terms of profitability, FZMD's ROE is +0.13%, compared to RMSL's ROE of -17961324.55%. Regarding short-term risk, FZMD is less volatile compared to RMSL. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check RMSL's competition here
FZMD vs ADMT Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, ADMT has a market cap of 5.6M. Regarding current trading prices, FZMD is priced at $0.02, while ADMT trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas ADMT's P/E ratio is -8.35. In terms of profitability, FZMD's ROE is +0.13%, compared to ADMT's ROE of -0.01%. Regarding short-term risk, FZMD is less volatile compared to ADMT. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check ADMT's competition here
FZMD vs QLIS Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, FZMD is priced at $0.02, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas QLIS's P/E ratio is 2.22. In terms of profitability, FZMD's ROE is +0.13%, compared to QLIS's ROE of -0.77%. Regarding short-term risk, FZMD and QLIS have similar daily volatility (0.00).Check QLIS's competition here
FZMD vs RHNMF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, FZMD is priced at $0.02, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, FZMD's ROE is +0.13%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, FZMD is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check RHNMF's competition here
FZMD vs ODYY Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, ODYY has a market cap of 5M. Regarding current trading prices, FZMD is priced at $0.02, while ODYY trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas ODYY's P/E ratio is -1.00. In terms of profitability, FZMD's ROE is +0.13%, compared to ODYY's ROE of +0.58%. Regarding short-term risk, FZMD is less volatile compared to ODYY. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check ODYY's competition here
FZMD vs VANIW Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, VANIW has a market cap of 3.4M. Regarding current trading prices, FZMD is priced at $0.02, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas VANIW's P/E ratio is N/A. In terms of profitability, FZMD's ROE is +0.13%, compared to VANIW's ROE of -3.17%. Regarding short-term risk, FZMD is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check VANIW's competition here
FZMD vs CYDX Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, CYDX has a market cap of 3.2M. Regarding current trading prices, FZMD is priced at $0.02, while CYDX trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas CYDX's P/E ratio is 0.79. In terms of profitability, FZMD's ROE is +0.13%, compared to CYDX's ROE of +0.13%. Regarding short-term risk, FZMD and CYDX have similar daily volatility (0.00).Check CYDX's competition here
FZMD vs LLBO Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, LLBO has a market cap of 3M. Regarding current trading prices, FZMD is priced at $0.02, while LLBO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas LLBO's P/E ratio is N/A. In terms of profitability, FZMD's ROE is +0.13%, compared to LLBO's ROE of +0.00%. Regarding short-term risk, FZMD and LLBO have similar daily volatility (0.00).Check LLBO's competition here
FZMD vs TBRIF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, TBRIF has a market cap of 2.8M. Regarding current trading prices, FZMD is priced at $0.02, while TBRIF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas TBRIF's P/E ratio is -0.96. In terms of profitability, FZMD's ROE is +0.13%, compared to TBRIF's ROE of +2.92%. Regarding short-term risk, FZMD and TBRIF have similar daily volatility (0.00).Check TBRIF's competition here
FZMD vs NGMDF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, NGMDF has a market cap of 2.4M. Regarding current trading prices, FZMD is priced at $0.02, while NGMDF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas NGMDF's P/E ratio is -1.04. In terms of profitability, FZMD's ROE is +0.13%, compared to NGMDF's ROE of +0.94%. Regarding short-term risk, FZMD and NGMDF have similar daily volatility (0.00).Check NGMDF's competition here
FZMD vs VYCO Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, VYCO has a market cap of 2.3M. Regarding current trading prices, FZMD is priced at $0.02, while VYCO trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas VYCO's P/E ratio is -7.00. In terms of profitability, FZMD's ROE is +0.13%, compared to VYCO's ROE of +0.02%. Regarding short-term risk, FZMD is less volatile compared to VYCO. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check VYCO's competition here
FZMD vs KLYG Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, KLYG has a market cap of 2.2M. Regarding current trading prices, FZMD is priced at $0.02, while KLYG trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas KLYG's P/E ratio is -17.68. In terms of profitability, FZMD's ROE is +0.13%, compared to KLYG's ROE of -0.19%. Regarding short-term risk, FZMD is less volatile compared to KLYG. This indicates potentially lower risk in terms of short-term price fluctuations for FZMD.Check KLYG's competition here
FZMD vs NUMD Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, NUMD has a market cap of 1.5M. Regarding current trading prices, FZMD is priced at $0.02, while NUMD trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas NUMD's P/E ratio is 1.74. In terms of profitability, FZMD's ROE is +0.13%, compared to NUMD's ROE of +0.22%. Regarding short-term risk, FZMD and NUMD have similar daily volatility (0.00).Check NUMD's competition here
FZMD vs ESMC Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, ESMC has a market cap of 1.3M. Regarding current trading prices, FZMD is priced at $0.02, while ESMC trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas ESMC's P/E ratio is -5.67. In terms of profitability, FZMD's ROE is +0.13%, compared to ESMC's ROE of -125.28%. Regarding short-term risk, FZMD and ESMC have similar daily volatility (0.00).Check ESMC's competition here
FZMD vs UAHC Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, UAHC has a market cap of 777.5K. Regarding current trading prices, FZMD is priced at $0.02, while UAHC trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas UAHC's P/E ratio is 0.56. In terms of profitability, FZMD's ROE is +0.13%, compared to UAHC's ROE of +0.04%. Regarding short-term risk, FZMD and UAHC have similar daily volatility (0.00).Check UAHC's competition here
FZMD vs ELXMF Comparison May 2026
FZMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FZMD stands at 2M. In comparison, ELXMF has a market cap of 541.2K. Regarding current trading prices, FZMD is priced at $0.02, while ELXMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FZMD currently has a P/E ratio of 1.35, whereas ELXMF's P/E ratio is -0.09. In terms of profitability, FZMD's ROE is +0.13%, compared to ELXMF's ROE of -0.40%. Regarding short-term risk, FZMD and ELXMF have similar daily volatility (0.00).Check ELXMF's competition here